So-Young(US:SY) 2 1 Shi Ji Jing Ji Bao Dao·2025-11-28 06:22Core Viewpoint - The medical beauty industry is experiencing a tug-of-war between upstream manufacturers and terminal institutions regarding product authorization and pricing, highlighting the need for regulatory compliance and market order [1][2]. Group 1: Industry Dynamics - The conflict centers around product authorization and compliance channels, reflecting a struggle for pricing power between upstream manufacturers and terminal medical beauty institutions [2]. - The medical beauty market in China is expanding, with unauthorized sales of related products becoming increasingly common, indicating a shift from "wild growth" to "regulated development" in the industry [2]. Group 2: Pricing Strategies - The market for "童颜针" (youthful beauty injections) has seen rapid growth, with its market size exceeding 30 billion yuan last year and projected to reach 100 billion yuan in five years [4]. - New Oxygen's introduction of low-priced "童颜针" projects has disrupted the pricing structure of upstream manufacturers, with prices significantly lower than official guidance [5]. - New Oxygen's pricing strategy aims to make medical beauty services more affordable, addressing the issue of consumers turning to unregulated "black medical beauty" services due to high prices [6]. Group 3: Compliance and Regulation - Concerns have been raised regarding New Oxygen's compliance, as it has been accused of using products without proper authorization, which could jeopardize consumer safety [7][8]. - Legal experts emphasize that medical institutions must procure medical devices from authorized sources to ensure traceability and compliance with regulations [8]. - The ongoing issues of counterfeit products and unauthorized sales highlight the urgent need for effective governance in the medical beauty industry [10][11]. Group 4: Consumer Protection - Consumers are advised to verify product authenticity through official channels and request proper documentation from medical institutions to safeguard their rights [12]. - The responsibility for ensuring compliance should not solely rest on consumers; a collaborative effort among manufacturers, institutions, and regulatory bodies is essential for sustainable development in the medical beauty sector [13].